The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?

by Ola Rominiyi, Yahia Al-Tamimi, Spencer J. Collis
Published 2019-03-01

Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma

by Natasha Carmell, Ola Rominiyi, Katie N. Myers, Connor McGarrity-Cottrell, Aurelie Vanderlinden, Nikita Lad, Eva Perroux-David, Sherif F. El-Khamisy, Malee Fernando, Katherine G. Finegan, Stephen Brown, Spencer J. Collis
Published 2021-02-01

Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study)

by Giles Critchley, Peter Hutchinson, Chittoor Rajaraman, Ola Rominiyi, Michael D Jenkinson, Alexis Joannides, Stuart Smith, Victoria Wykes, Stephen John Price, Puneet Plaha, Fardad Taghizadeh Afshari, Erminia Albanese, Neil U Barua, Huan Wee Chan, Thomas Flannery, Michael TC Poon, Georgios Solomou, Anna Solth, Surash Surash, Helen Bulbeck
Published 2020-08-01